Literature DB >> 7849037

cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom.

S Nishida1, T Fujita, N Kohno, H Atoda, T Morita, H Takeya, I Kido, M J Paine, S Kawabata, S Iwanaga.   

Abstract

The complete amino acid sequence of ecarin is deduced from the nucleotide sequence of a cDNA clone isolated by screening a venomous gland cDNA library of Kenyan Echis carinatus. The cDNA sequence with 2379 base pairs encodes an open reading frame of 616 amino acids with a remarkable sequence homology to the putative precursor protein of trigramin from Trimeresurus gramineus venom (61% identity) and a large hemorrhagin, jararhagin, from the pit viper Bothrops jararaca venom (62% identity). Thus, ecarin, as well as jararhagin and trigramin, is translated as a precursor protein, which may be processed posttranslationally. The ecarin proprotein has a "cysteine switch" motif (-Pro-Lys-Met-Cys-Gly-Val-) similar to that involved in the activation of matrix metalloproteinase zymogens. The processed mature protein consists of 426 amino acid residues (residues 191-616), showing the strongest sequence similarity with that of Russell's viper venom factor X activator (RVV-X) heavy chain (64% identity). Like RVV-X heavy chain, ecarin contains metalloproteinase, disintegrin, and cysteine-rich domains. The metalloproteinase domain has a typical zinc-chelating sequence (-His-Glu-Xaa-Xaa-His-Xaa-Xaa-Gly-Xaa-Xaa-His-), as found in crayfish astacin. In the disintegrin domain of ecarin, the Arg-Gly-Asp sequence is replaced by Arg-Asp-Asp, as found in the disintegrin domains of RVV-X heavy chain (Arg-Asp-Glu) and a guinea pig sperm fusion protein, PH-30 beta (Thr-Asp-Glu). These findings show that while there are structural and evolutionary relationships among these proteins, each has a unique functional activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7849037     DOI: 10.1021/bi00005a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Authors:  N Lubenow; A Greinacher
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

2.  Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.

Authors:  Juan J Calvete; Pedro Cid; Libia Sanz; Alvaro Segura; Mauren Villalta; María Herrera; Guillermo León; Robert Harrison; Nandul Durfa; Abdusalami Nasidi; R David G Theakston; David A Warrell; José María Gutiérrez
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

3.  Effects of snake venom proteases on human fibrinogen chains.

Authors:  Alessio Cortelazzo; Roberto Guerranti; Luca Bini; Nnadozie Hope-Onyekwere; Chiara Muzzi; Roberto Leoncini; Roberto Pagani
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

4.  CCSV-MPase, a novel procoagulant metalloproteinase from Cerastes cerastes venom: purification, biochemical characterization and protein identification.

Authors:  Fatah Chérifi; Jean-Claude Rousselle; Abdelkader Namane; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2010-10       Impact factor: 2.371

5.  A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning.

Authors:  Márcia B Silva; Mirta Schattner; Celso R R Ramos; Inácio L M Junqueira-de-Azevedo; Míriam C Guarnieri; María A Lazzari; Claudio A M Sampaio; Roberto G Pozner; Janaina S Ventura; Paulo L Ho; Ana M Chudzinski-Tavassi
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

6.  Membrane binding by prothrombin mediates its constrained presentation to prothrombinase for cleavage.

Authors:  Harlan N Bradford; Steven J Orcutt; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

7.  Expression and characterization of recombinant ecarin.

Authors:  Anna Jonebring; Ute Lange; Elke Bucha; Johanna Deinum; Margareta Elg; Ann Lövgren
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

8.  Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.

Authors:  Simon C Wagstaff; Gavin D Laing; R David G Theakston; Christina Papaspyridis; Robert A Harrison
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

9.  Snake Venom Cytotoxins, Phospholipase A2s, and Zn2+-dependent Metalloproteinases: Mechanisms of Action and Pharmacological Relevance.

Authors:  Sardar E Gasanov; Ruben K Dagda; Eppie D Rael
Journal:  J Clin Toxicol       Date:  2014-01-25

Review 10.  Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites.

Authors:  R Manjunatha Kini; Cho Yeow Koh
Journal:  Toxins (Basel)       Date:  2016-09-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.